Entity Common Stock, Shares Outstanding of Carisma Therapeutics Inc. from 12 May 2014 to 05 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Carisma Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 May 2014 to 05 Nov 2025.
  • Carisma Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending 05 Nov 2025 was 41,845,078, a 0.23% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Carisma Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 41,845,078 +94,969 +0.23% 05 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 41,788,096 +243,121 +0.58% 05 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 41,788,096 +245,562 +0.59% 26 Mar 2025 10-K/A 29 Apr 2025 2024 FY
Q3 2024 41,750,109 +1,393,303 +3.5% 05 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 41,544,975 +1,260,130 +3.1% 06 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 41,542,534 -161,949,668 -80% 15 Mar 2024 10-K 01 Apr 2024 2023 FY
Q3 2023 40,356,806 -162,400,206 -80% 06 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 40,284,845 -159,178,800 -80% 09 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 203,492,202 +4,028,557 +2% 21 Feb 2023 10-K 28 Feb 2023 2022 FY
Q3 2022 202,757,012 +3,293,367 +1.7% 31 Oct 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 199,463,645 +3,461,025 +1.8% 01 Aug 2022 10-Q/A 25 Aug 2022 2022 Q2
Q1 2022 199,463,645 +31,885,008 +19% 02 May 2022 10-Q 09 May 2022 2022 Q1
Q3 2021 199,463,645 +70,124,028 +54% 01 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 196,002,620 +78,830,984 +67% 02 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 167,578,637 +57,589,869 +52% 08 Mar 2021 10-K 15 Mar 2021 2020 FY
Q3 2020 129,339,617 +24,660,226 +24% 02 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 117,171,636 +15,905,740 +16% 03 Aug 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 109,988,768 +32,532,588 +42% 29 Feb 2020 10-K 16 Mar 2020 2019 FY
Q3 2019 104,679,391 +27,223,211 +35% 07 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 101,265,896 +24,254,897 +31% 06 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 77,456,180 +34,350,714 +80% 27 Feb 2019 10-K 01 Mar 2019 2018 FY
Q3 2018 77,456,180 07 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 77,010,999 +52,310,253 +212% 10 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 43,105,466 +18,404,720 +75% 30 Mar 2018 10-K 02 Apr 2018 2017 FY
Q4 2017 31,831,995 15 Nov 2017 10-Q 17 Nov 2017 2017 Q3
Q2 2017 24,700,746 +4,642,448 +23% 11 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 24,700,746 +5,015,871 +25% 23 Mar 2017 10-K 24 Mar 2017 2016 FY
Q3 2016 24,238,369 +4,651,092 +24% 31 Oct 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 20,058,298 +679,013 +3.5% 31 Jul 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 19,684,875 +313,464 +1.6% 15 Mar 2016 10-K 25 Mar 2016 2015 FY
Q3 2015 19,587,277 +3,297,918 +20% 31 Oct 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 19,379,285 +3,106,562 +19% 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 19,371,411 +3,109,562 +19% 17 Apr 2015 10-Q 30 Apr 2015 2015 Q1
Q3 2014 16,289,359 06 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 16,272,723 08 Aug 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 16,261,849 12 May 2014 10-Q 15 May 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.